TSH-secreting pituitary adenomas: Follow-up of 11 cases and review of the literature

Pituitary

Volumn 10, Issue 3, 2007, Pages 307-310

  Ness Abramof, Rosane ^a   Ishay, Avraham ^b   Harel, Gideon ^c   Sylvetzky, Noa ^d   Baron, Elzbieta ^e   Greenman, Yona ^f   Shimon, Ilan ^g  

^a MEIR MEDICAL CENTER   (Israel)

^b HAEMEK MEDICAL CENTER   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e CARMEL MEDICAL CENTER   (Israel)

^f TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^g TEL AVIV UNIVERSITY   (Israel)

Author keywords

Hyperthyroidism; Pituitary adenoma; Somatostatin analogs; TSH secreting tumors

Indexed keywords

ANGIOPEPTIN; CABERGOLINE; GROWTH HORMONE; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CANCER SIZE; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; EARLY DIAGNOSIS; FEMALE; GROWTH HORMONE RELEASE; HUMAN; HYPERTHYROIDISM; IMMUNOHISTOCHEMISTRY; ISRAEL; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE CARE; PRIORITY JOURNAL; THYROTROPIN SECRETING ADENOMA; THYROXINE BLOOD LEVEL; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HORMONE ANTAGONISTS; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; SOMATOSTATIN; THYROTROPIN; THYROXINE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TRIIODOTHYRONINE;

EID: 35848947220     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-007-0020-3     Document Type: Article

References (17)

1. Beck-Peccoz P, Brucker-Davis F, Persani L (1996) Thyrotropin-secreting pituitary tumors. Endocr Rev 17:610-638
2. Greenman Y, Melmed S (2002) Thyrotropin-secreting pituitary tumors. In: Melmed S, (ed) The Pituitary. Blackwell Science Inc., Boston, pp 561-574
3. Jailer JW, Holub DA (1960) Remission of Graves' disease following radiotherapy of a pituitary neoplasm. Am J Med 28:497-500
4. Valdes Socin H, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A (2003) The changing spectrum of TSH-secreting pituitary adenomas: Diagnosis and management of 43 patients. Eur J Endocrinol 148:433-442
5. Beckers A, Abs R, Mahler C, Vandalem JL, Pirens G, Hennen G, Stevenaert A (1991) Thyrotropin secreting pituitary adenomas: Report of seven cases. J Clin Endocrinol Metab 72:477-483
6. Shimon I, Nass D, Gross JD (2001) Pituitary macroadenoma secreting thyrotropin and growth hormone: Remission of bihormonal hypersecretion in response to lanreotide therapy. Pituitary 4:265-269
7. Chanson P, Weintraub BD, Harris AG (1993) Octreotide therapy for thyroid stimulating hormone secreting pituitary adenomas a follow up of 52 patients. Ann Intern Med 119:236-240
8. Mannavola D, Persani L, Vanucchi G, Zanardelli M, Fugazzola L, Verga U, Facchetti M, Beck-Peccoz P (2005) Different responses to chronic somatostatin analogues in patients with central hyperthyroidism. Clin Endocrinol 62:176-181
9. Beck-Peccoz P, Persani L (2002) Medical management of thyrotropin-secreting pituitary adenomas. Pituitary 5:83-88
10. Refetoff S, Weiss RE, Usala SJ (1993) The syndromes of resistance to thyroid hormone. Endocr Rev 14:348-399
11. Safer JD, Colan SD, Fraser LM, Wondisford FE (2001) A pituitary tumor in a patient with thyroid hormone resistance: A diagnostic dilemma. Thyroid 11:281-291
12. Losa M, Giovanelli M, Persani L, Mortini P, Faglia G, Beck-Peccoz P (1996) Criteria of cure and follow up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 81:3084-3090
13. Collie RB, Collie MJ (2005) Extracranial thyroid stimulating hormone secreting ectopic pituitary adenoma of the nasopharynx. Otolaryngol Head Neck Surg 133:453-454
14. Brucker-Davis F, Oldfield E, Skarulis MC, Doppman JL, Weintraub BD (1999) Thyrotropin-secreting pituitary tumors: Diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84:476-486
15. Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P (2001) Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 86:2849-2853
16. Kuhn JM, Arlot S, Lefebvre H, Caron P, Cortet-Rudelli C, Archambaud F, Chanson P, Tabarin A, Goth MI, Blomberg J, Catus F, Ispas S, Beck-Peccoz P (2000) Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide. J Clin Endocrinol Metab 85:1487-1491
17. Mulinda JR, Hasinki S, Rose LI (1999) Successful therapy for a mixed thyrotropin-and-prolactin secreting pituitary macroadenoma with carbegoline. Endocr Pract 5:76-79